![](/img/cover-not-exists.png)
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
La Rosa, Alberto M, Harrison, Linda J, Taiwo, Babafemi, Wallis, Carole L, Zheng, Lu, Kim, Peter, Kumarasamy, Nagalingeswaran, Hosseinipour, Mina C, Jarocki, Bernadette, Mellors, John W, Collier, Ann CLanguage:
english
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(16)30011-X
Date:
April, 2016
File:
PDF, 519 KB
english, 2016